CGEM Insider Transactions — Page 4
386 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 301–386; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| BioImpact Capital LLC | TenPercentOwner | 2021-08-31 | Sale | 1,553.0 | $30.14 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-08-31 | Sale | 1,553.0 | $30.14 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-08-31 | Sale | 1,553.0 | $30.14 |
| BioImpact Capital LLC | TenPercentOwner | 2021-08-31 | Sale | 1,285.0 | $29.43 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-08-31 | Sale | 1,285.0 | $29.43 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-08-31 | Sale | 1,285.0 | $29.43 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-31 | Sale | 1,553.0 | $30.14 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-31 | Sale | 215.0 | $30.14 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-31 | Sale | 1,285.0 | $29.43 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-31 | Sale | 177.0 | $29.43 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-30 | Sale | 31,001.0 | $29.3 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-30 | Sale | 4,285.0 | $29.3 |
| BioImpact Capital LLC | TenPercentOwner | 2021-08-30 | Sale | 31,001.0 | $29.3 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-08-30 | Sale | 31,001.0 | $29.3 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-08-30 | Sale | 31,001.0 | $29.3 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-27 | Sale | 13,357.0 | $29.09 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-27 | Sale | 1,846.0 | $29.09 |
| BioImpact Capital LLC | TenPercentOwner | 2021-08-27 | Sale | 13,357.0 | $29.09 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-08-27 | Sale | 13,357.0 | $29.09 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-08-27 | Sale | 13,357.0 | $29.09 |
| MPM Oncology Impact Management LP | TenPercentOwner | 2021-08-25 | Sale | 1,713.0 | $29.09 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-08-25 | Sale | 1,713.0 | $29.09 |
| MPM Oncology Impact Management GP LLC | TenPercentOwner | 2021-08-25 | Sale | 1,713.0 | $29.09 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-08-25 | Sale | 1,713.0 | $29.09 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-25 | Sale | 1,713.0 | $29.09 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-25 | Sale | 237.0 | $29.09 |
| MPM Oncology Impact Management LP | TenPercentOwner | 2021-08-24 | Sale | 50,822.0 | $29.48 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-08-24 | Sale | 50,822.0 | $29.48 |
| MPM Oncology Impact Management GP LLC | TenPercentOwner | 2021-08-24 | Sale | 50,822.0 | $29.48 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-08-24 | Sale | 50,822.0 | $29.48 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-24 | Sale | 50,882.0 | $29.48 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-24 | Sale | 7,025.0 | $29.48 |
| Zawel Leigh | See Remarks | 2021-08-23 | Sale | 28,118.0 | $29.0 |
| MPM Oncology Impact Management LP | TenPercentOwner | 2021-08-23 | Sale | 53,359.0 | $29.11 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-08-23 | Sale | 53,359.0 | $29.11 |
| MPM Oncology Impact Management GP LLC | TenPercentOwner | 2021-08-23 | Sale | 53,359.0 | $29.11 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-08-23 | Sale | 53,359.0 | $29.11 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-23 | Sale | 53,359.0 | $29.11 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-23 | Sale | 7,376.0 | $29.11 |
| Zawel Leigh | See Remarks | 2021-08-23 | Sale | 28,118.0 | $29.0 |
| Michaelson Jennifer | See Remarks | 2021-08-18 | Sale | 1,137.0 | $28.07 |
| Michaelson Jennifer | See Remarks | 2021-08-18 | Sale | 2,863.0 | $27.5 |
| Michaelson Jennifer | See Remarks | 2021-08-18 | Sale | 1,137.0 | $28.07 |
| Michaelson Jennifer | See Remarks | 2021-08-18 | Sale | 2,863.0 | $27.5 |
| MPM Oncology Impact Management LP | TenPercentOwner | 2021-08-11 | Sale | 2,510.0 | $29.05 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-08-11 | Sale | 2,510.0 | $29.05 |
| MPM Oncology Impact Management GP LLC | TenPercentOwner | 2021-08-11 | Sale | 2,510.0 | $29.05 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-08-11 | Sale | 2,510.0 | $29.05 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-11 | Sale | 2,510.0 | $29.05 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-08-11 | Sale | 347.0 | $29.05 |
| Zawel Leigh | See Remarks | 2021-08-10 | Sale | 1,817.0 | $28.49 |
| Zawel Leigh | See Remarks | 2021-08-10 | Sale | 3,191.0 | $27.34 |
| Zawel Leigh | See Remarks | 2021-08-10 | Sale | 1,906.0 | $26.5 |
| Baeuerle Patrick | See Remarks | 2021-08-10 | Sale | 11,000.0 | $27.0 |
| Zawel Leigh | See Remarks | 2021-08-10 | Sale | 1,817.0 | $28.49 |
| Zawel Leigh | See Remarks | 2021-08-10 | Sale | 3,191.0 | $27.34 |
| Zawel Leigh | See Remarks | 2021-08-10 | Sale | 1,906.0 | $26.5 |
| Zawel Leigh | See Remarks | 2021-08-09 | Sale | 1,700.0 | $27.11 |
| Zawel Leigh | See Remarks | 2021-08-09 | Sale | 19,504.0 | $26.52 |
| Zawel Leigh | See Remarks | 2021-08-09 | Sale | 1,700.0 | $27.11 |
| Zawel Leigh | See Remarks | 2021-08-09 | Sale | 19,504.0 | $26.52 |
| MPM Oncology Impact Management LP | TenPercentOwner | 2021-01-12 | Purchase | 300,000.0 | $21.0 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-01-12 | Purchase | 300,000.0 | $21.0 |
| MPM Oncology Impact Management GP LLC | TenPercentOwner | 2021-01-12 | Purchase | 300,000.0 | $21.0 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-01-12 | Purchase | 300,000.0 | $21.0 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-01-12 | Purchase | 300,000.0 | $21.0 |
| Jovan-Embiricos Morana | Director,TenPercentOwner | 2021-01-12 | Purchase | 104,762.0 | $21.0 |
| Globeways Holdings Ltd | TenPercentOwner | 2021-01-12 | Purchase | 104,762.0 | $21.0 |
| F2 MG Ltd | TenPercentOwner | 2021-01-12 | Purchase | 104,762.0 | $21.0 |
| F2 - TPO Investments LLC | TenPercentOwner | 2021-01-12 | Purchase | 104,762.0 | $21.0 |
| F2 Bio TD, LLC | TenPercentOwner | 2021-01-12 | Purchase | 104,762.0 | $21.0 |
| F2 Vision SCS | TenPercentOwner | 2021-01-12 | Purchase | 104,762.0 | $21.0 |
| F2 MC, LLC | TenPercentOwner | 2021-01-12 | Purchase | 104,762.0 | $21.0 |
| F2 Bioscience I 2017 Ltd | TenPercentOwner | 2021-01-12 | Purchase | 104,762.0 | $21.0 |
| F2 GC, LLC | TenPercentOwner | 2021-01-12 | Purchase | 104,762.0 | $21.0 |
| Jovan-Embiricos Morana | Director,TenPercentOwner | 2021-01-12 | Purchase | 95,238.0 | $21.0 |
| Globeways Holdings Ltd | TenPercentOwner | 2021-01-12 | Purchase | 95,238.0 | $21.0 |
| F2 MG Ltd | TenPercentOwner | 2021-01-12 | Purchase | 95,238.0 | $21.0 |
| F2 - TPO Investments LLC | TenPercentOwner | 2021-01-12 | Purchase | 95,238.0 | $21.0 |
| F2 Bio TD, LLC | TenPercentOwner | 2021-01-12 | Purchase | 95,238.0 | $21.0 |
| F2 Vision SCS | TenPercentOwner | 2021-01-12 | Purchase | 95,238.0 | $21.0 |
| F2 MC, LLC | TenPercentOwner | 2021-01-12 | Purchase | 95,238.0 | $21.0 |
| F2 Bioscience I 2017 Ltd | TenPercentOwner | 2021-01-12 | Purchase | 95,238.0 | $21.0 |
| F2 GC, LLC | TenPercentOwner | 2021-01-12 | Purchase | 95,238.0 | $21.0 |
| Trigilio Jeffrey | Chief Financial Officer | 2021-01-12 | Purchase | 2,250.0 | $21.0 |
| Hughes Owen | President and CEO | 2021-01-12 | Purchase | 2,500.0 | $21.0 |